These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3839286)

  • 21. Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure.
    Coen G; Bondatti F; Donato G; Mazzaferro S; Pasquali M; Rosini S; Sardella D; Taggi F
    J Steroid Biochem Mol Biol; 1992 Sep; 42(8):823-9. PubMed ID: 1525043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous calcitriol in the treatment of the refractory secondary hyperparathyroidism of terminal chronic kidney failure].
    Almirall J; Torregrosa V; Arrizabalaga P; Cases A; Oliva J
    Med Clin (Barc); 1994 Mar; 102(9):325-8. PubMed ID: 8164458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Levels of dihydroxyvitamin D3 and hydroxyvitamin D in patients with chronic renal insufficiency].
    Lazarević M; Poskurica M; Djukanović Lj; Babić Lj; Metiljević S
    Srp Arh Celok Lek; 1996; 124 Suppl 1():108-11. PubMed ID: 9102866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium metabolism and calciotropic hormone levels in Gitelman's syndrome.
    Colussi G; Macaluso M; Brunati C; Minetti L
    Miner Electrolyte Metab; 1994; 20(5):294-301. PubMed ID: 7700218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and biologic effects of calcitriol in normal humans.
    Levine BS; Singer FR; Bryce GF; Mallon JP; Miller ON; Coburn JW
    J Lab Clin Med; 1985 Feb; 105(2):239-46. PubMed ID: 3838330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrarenal production of calcitriol.
    Dusso A; Finch J; Delmez J; Rapp N; Lopez-Hilker S; Brown A; Slatopolsky E
    Kidney Int Suppl; 1990 Sep; 29():S36-40. PubMed ID: 2214546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?
    Christiansen C; Rødbro P; Christensen MS; Hartnack B
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide.
    Santos F; Smith MJ; Chan JC
    Am J Dis Child; 1986 Feb; 140(2):139-42. PubMed ID: 3753816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.
    Baker LR; Abrams L; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int; 1989 Feb; 35(2):661-9. PubMed ID: 2651758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators.
    Chan JC; McEnery PT; Chinchilli VM; Abitbol CL; Boineau FG; Friedman AL; Lum GM; Roy S; Ruley EJ; Strife CF
    J Pediatr; 1994 Apr; 124(4):520-8. PubMed ID: 8151464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 1,25(OH)2D3 administration on bone in patients with renal failure.
    Malluche HH; Faugere MC
    Kidney Int Suppl; 1990 Sep; 29():S48-53. PubMed ID: 2214547
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of calcitriol treatment on psoriasis in hemodialysis patient: a case report.
    Gao GW; Lin SH; Chyr SH; Lin YF; Tseng SS; Lu KC
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):263-5. PubMed ID: 7780885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with 1,25(QH)2D3 in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Costantini S; Bonucci E; Bondatti F; Manni M; Pasquali M; Sardella D; Taggi F
    Contrib Nephrol; 1991; 90():183-8. PubMed ID: 1959344
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical evaluation of bone metabolism after renal transplantation to support the theory to perform 1,25(OH)2D3 pulse therapy before transplantation.
    Hyodo T; Kumano K; Endo T; Mori T; Takagi Y; Mashimo S; Sakai T; Koshiba K
    Nephron; 1996; 73(4):723. PubMed ID: 8856286
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose.
    Papapoulos SE; Clemens TL; Sandler LM; Fraher LJ; Winer J; O'Riordan JL
    Clin Sci (Lond); 1982 Apr; 62(4):427-9. PubMed ID: 6896025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of stimulating effect on thyrotropic and lactotropic secretion during prolonged calcitriol administration.
    Zofková I; Táborský P; Bednár J; Nedvídková J
    Exp Clin Endocrinol; 1992; 99(1):54-6. PubMed ID: 1628699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis, 1,25(OH)2 vitamin D3 and renal failure.
    De Francisco AL; Cotorruelo JG; Riancho JA; Amado JA; Sanz De Castro S; Zubimendi A; Arias M
    Nephrol Dial Transplant; 1990; 5(4):293-4. PubMed ID: 2113226
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription of calcium carbonate to nondialyzed patients with a supranormal serum 1,25(OH)2D3 concentration.
    Okada K; Takahashi S; Nagura Y; Hatano M
    Nephron; 1991; 59(4):683-4. PubMed ID: 1766521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.